Literature DB >> 26614494

Cardiac syndrome X in Ireland: incidence and phenotype.

J Dollard1,2, P Kearney3, T G Dinan4,5.   

Abstract

BACKGROUND: Cardiac syndrome X (CSX) is typical angina pectoris with objective signs of myocardial ischaemia despite a normal coronary angiogram and may be due to microvascular dysfunction. The incidence of CSX has not been greatly investigated worldwide and its incidence in Ireland is unknown. AIMS: We aimed to determine the incidence of CSX in Cork University Hospital (CUH) and to establish the phenotype of the typical Irish CSX patient.
METHODS: All patients undergoing coronary angiography in CUH during regular working hours over a 3-month period were investigated. CSX was diagnosed using standard criteria. An extended recruitment period of 14 months allowed enrolment of a sufficient number of CSX patients to enable phenotyping.
RESULTS: Only 5 of 372 (1.3 %) patients undergoing angiography to investigate chest pain met the diagnostic criteria for CSX. None were given a discharge diagnosis of CSX or received cardiology follow-up. Irish CSX patients were predominantly female (88 %) with a mean age of 59.2 ± 6.6 years. Although they were significantly less functionally limited than patients with obstructive CAD, they had an equally substantial impairment in quality of life.
CONCLUSIONS: CSX is relatively uncommon in Ireland and is most frequently seen in middle-aged women with hyperlipidaemia. It has significant impacts on patients' quality of life. None of the CSX patients were diagnosed as such, highlighting the lack of awareness or acceptance of this condition in Ireland. These patients require diagnosis and active cardiology follow-up to effectively manage their symptoms.

Entities:  

Keywords:  Angina pectoris; Epidemiology; Microvascular angina; Normal coronary arteries

Mesh:

Year:  2015        PMID: 26614494     DOI: 10.1007/s11845-015-1382-6

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  6 in total

Review 1.  Primary coronary microvascular dysfunction: clinical presentation, pathophysiology, and management.

Authors:  Gaetano Antonio Lanza; Filippo Crea
Journal:  Circulation       Date:  2010-06-01       Impact factor: 29.690

2.  A prospective study of C-reactive protein as a state marker in Cardiac Syndrome X.

Authors:  James Dollard; Peter Kearney; Gerard Clarke; Gerard Moloney; John F Cryan; Timothy G Dinan
Journal:  Brain Behav Immun       Date:  2014-07-24       Impact factor: 7.217

3.  Vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 serum level in patients with chest pain and normal coronary arteries (syndrome X).

Authors:  D Tousoulis; G J Davies; G Asimakopoulos; H Homaei; E Zouridakis; N Ahmed; J C Kaski
Journal:  Clin Cardiol       Date:  2001-04       Impact factor: 2.882

Review 4.  Definitions and incidence of cardiac syndrome X: review and analysis of clinical data.

Authors:  I A C Vermeltfoort; P G H M Raijmakers; I I Riphagen; D A M Odekerken; A F M Kuijper; A Zwijnenburg; G J J Teule
Journal:  Clin Res Cardiol       Date:  2010-04-21       Impact factor: 5.460

5.  Development and evaluation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease.

Authors:  J A Spertus; J A Winder; T A Dewhurst; R A Deyo; J Prodzinski; M McDonell; S D Fihn
Journal:  J Am Coll Cardiol       Date:  1995-02       Impact factor: 24.094

6.  Long-term prognosis of patients with cardiac syndrome X: a review.

Authors:  I A C Vermeltfoort; G J J Teule; A B van Dijk; H J Muntinga; P G H M Raijmakers
Journal:  Neth Heart J       Date:  2012-09       Impact factor: 2.380

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.